The Wellness Practice Playbook
GLP-1s are driving explosive growth in cash-pay clinics - but they’re also creating serious legal exposure for the unprepared. In this episode, Alex Sidorenkov sits down with David Caddell, President of EC3Health, to unpack the compliance must-knows every clinic needs before promoting semaglutide or tirzepatide. * What’s legal, what’s risky, and how to choose a compounding pharmacy * How to structure your GLP-1 offering for long-term revenue * Why HRT and peptide therapy should follow GLP-1s in the patient journey If you’re selling semaglutide or tirzepatide or planning to - don’t miss this. It could protect your business and position you for long-term growth. _____ This episode of The Wellness Practice Playbook is also available for streaming on our website, YouTube, Apple Podcast, and Spotify.
8 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de The Wellness Practice Playbook!